Sankhajyoti Charit

[Sankhajyoti Charit @SankhajyotiC]

@GorzibRoman @OrganizationTao @AllogeneTx Yes they only care about funding but will never get the trust from the shareholders. Stock price pump to $4.5 and in next 2 days below $1.9. They will dilute the shareholders and keep their project alive. That's the reason the stock price move from $50 to $2 now from 2020.

[Sankhajyoti Charit @SankhajyotiC]

@chillipickle7 Yes they loot the investors. Stock price is getting down from $50 to $1 in the last 6 years. It will again hit the below $1. Such a crap $ALLO

[Sankhajyoti Charit @SankhajyotiC]

@AndyBerman6 @PersimmonTI Such a scam to the existing shareholder. Investors should stay away from @AllogeneTx

[Sankhajyoti Charit @SankhajyotiC]

@GorzibRoman @AllogeneTx $ALLO published the trial results and highly dilute the existing shareholders. A big negative for the investors

[Sankhajyoti Charit @SankhajyotiC]

@MarcJacksonLA Full scam company! First pumped the price on Monday and dilute the existing shareholders.

[Sankhajyoti Charit @SankhajyotiC]

HIMS is no longer a "hair loss company." It is becoming a data-driven health platform. If they successfully bridge the gap into longevity and diagnostics this year, the path to a $100 stock by 2028 looks fundamentally supported by their current revenue trajectory.

[Sankhajyoti Charit @SankhajyotiC]

$HIMS is shifting from a simple online pharmacy to a comprehensive health ecosystem. Their strategy focuses on moving beyond "pills in a box" toward data-driven, long-term health management.

Institutional ownership indicates it clearly:

[Sankhajyoti Charit @SankhajyotiC]

International Footprint: With the acquisition of ZAVA in Europe and a planned 2026 launch in Canada, HIMS is positioning itself to be the global leader in DTC (Direct-to-Consumer) healthcare, moving early into markets where generic semaglutide (weight loss) is becoming available.

[Sankhajyoti Charit @SankhajyotiC]

Diagnostics & Lab Testing:Through the acquisition of YourBio Health,HIMS integrating blood testing & diagnostics directly into their app.This allows HIMS to offer "precision medicine"-using actual lab data to prescribe the dosage which significantly increases patient retention.

[Sankhajyoti Charit @SankhajyotiC]

Expansion into "Longevity" Verticals:HIMS aggressively moving into multi-billion dollar categories including Menopause,Testosterone (Low-T),and https://t.co/PqUzrX3GOa 2026, they aim to be a"one-stop shop"for aging,keeping users on the platform for decades rather than few months.

[Sankhajyoti Charit @SankhajyotiC]

Vertical Integration & Manufacturing:By acquiring 503B compounding facilities,HIMS is taking control of its own supply chain.This allows them to create proprietary,low-cost versions of popular drugs(like personalized weight-loss compounds)that competitors cannot easily replicate.

[Ziven @Ziven_io]

JUST IN: 🚀 @HIVEDigitalTech surpasses 14 EH/s in Bitcoin mining with a $315M annual revenue run rate and 55% profit margin. Plans to expand to 18 EH/s by summer's end and 25 EH/s by Thanksgiving. Paraguay operations set to boost daily Bitcoin output to 12 BTC. $HIVE

[Sankhajyoti Charit @SankhajyotiC]

@anthonysagami @HIVEDigitalTech HIVE does not care about the shareholders and significantly dilute the share. Hence share price always goes down in the longer term.

[Sankhajyoti Charit @SankhajyotiC]

@StockTickerZone It's only option contract positions of the insider. It does not impact the actual holding of the insiders

[Sankhajyoti Charit @SankhajyotiC]

@miningstockinfo @HIVEDigitalTech @HIVEDigitalTech In last 1 year EH/s improved efficiently, bitcoin price is also increased a lot but your share price is down 44% in last 1 year

[HARA @HARA_JasmyCFO]

#Jasmy's strong community and the decentralization of tokens that support it.
See good article.

[Sankhajyoti Charit @SankhajyotiC]

@CaptainJasmy @HARA_JasmyCFO @0xjasmy @JasmyMGT @JanctionMGT If there is no upcoming news, it will gradually sink towards an all time low again. The technical indicator is very worrying. Hopefully the upcoming roadmap will give some indications

[Sankhajyoti Charit @SankhajyotiC]

https://t.co/4YOsty8KZo

Can #Jasmy it hit its $4.99 again? it’s a long climb. Experts argue its massive supply could cap gains unless adoption explodes. Yet, with AI integration, legal status in Japan, Will it moon? Maybe not tomorrow, but this data driven rocket is warming up!

[Dear Bitcoiner ⚡️ @DearBitcoiner]

The 888,888th #Bitcoin block is in the books. The countdown to scarcity just hit another milestone.

[Sankhajyoti Charit @SankhajyotiC]

It will be in the near future soon, patience is the key😃

[Coinvo @Coinvo]

🟢 BULLISH:

The CEO of Bitwise recently said that he believes #Bitcoin is going straight to $1 million!